The endocrinologist walks through how the GLP-1 pathway grew into newer therapies used for weight loss. An evergreen explainer.
Recap by typeshit. Post by Facebook on Facebook.
In rats and minipigs, doses too small to cut weight still reduced heart scarring and stiffness tied to a common heart failure type, researchers report.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
A social post points to a Phase 3 obesity trial where people on the highest retatrutide dose lost 28.3% on average, and hints at benefits beyond weight loss.
An investor analysis ranks five Lilly milestones by return. The 2008 ImClone deal turned $1,000 into about $58,000, while buying at Zepbound's approval returned 91%.
Loading…